Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

IQVIA logoIQVIA IQV

IQVIA said its revenues for Q2 2024 increased $86 million (2.3%) from the same period a year earlier, and its revenues for the first six months increased $171 million (2.3%). Constant currency revenue growth was approximately $130 million (3.5%) for Q2 and approximately $235 million (3.2%) for the first six months.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. IQVIA said its revenues for Q2 2024 increased $86 million (2.3%) from the same period a year earlier, and its revenues for the first six months increased $171 million (2.3%). Constant currency revenue growth was approximately $130 million (3.5%) for Q2 and approximately $235 million (3.2%) for the first six months.

  2. The company said Research & Development Solutions revenues rose $51 million (2.4%) year over year to $2,147 million in Q2. It said contracted backlog went from $29.7 billion to $30.6 billion, and that it expects approximately $7.8 billion of this backlog to convert to revenues in the next 12 months.

  3. IQVIA said its effective income tax rate was 17.2% in Q2 2024 versus 21.6% in Q2 2023, and 16.0% for the first six months compared with 20.6% in the prior-year first six months. The company cited changes in the geographic mix of earnings between U.S. and foreign tax jurisdictions as the reason.

  4. The company said operating cash flow for the first six months of 2024 increased $291 million from the same period a year earlier, and that its cash balance as of June 30 was $1,545 million. It did not repurchase any shares under the Repurchase Program in the first six months, and its remaining authorization is $2,363 million.

Key figures

Quarter ended June 30, 2024

Revenue
$3.8B
Operating income
$520M
Net income
$363M
EPS
$1.97
Gross profit
$863M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q2 and First-Half Revenue Growth

IQVIA said its revenues for Q2 2024 increased $86 million (2.3%) from the same period a year earlier, and its revenues for the first six months increased $171 million (2.3%). Constant currency revenue growth was approximately $130 million (3.5%) for Q2 and approximately $235 million (3.2%) for the first six months.

Source · Based on the MD&A text of the filing

Research & Development Solutions Revenue and Backlog

The company said Research & Development Solutions revenues rose $51 million (2.4%) year over year to $2,147 million in Q2. It said contracted backlog went from $29.7 billion to $30.6 billion, and that it expects approximately $7.8 billion of this backlog to convert to revenues in the next 12 months.

Source · Based on the MD&A text of the filing

Lower Effective Tax Rate

IQVIA said its effective income tax rate was 17.2% in Q2 2024 versus 21.6% in Q2 2023, and 16.0% for the first six months compared with 20.6% in the prior-year first six months. The company cited changes in the geographic mix of earnings between U.S. and foreign tax jurisdictions as the reason.

Source · Based on the MD&A text of the filing

First-Half Operating Cash Flow and Share Repurchases

The company said operating cash flow for the first six months of 2024 increased $291 million from the same period a year earlier, and that its cash balance as of June 30 was $1,545 million. It did not repurchase any shares under the Repurchase Program in the first six months, and its remaining authorization is $2,363 million.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.